Update on Pneumovax23 vaccine supplies
Due to increased global demand, supplies of Pneumovax®23 (Pneumococcal Polysaccharide Vaccine) have been constrained since 2017. In consequence, guidance has been issued on prioritisation of the available stock, most recently in CMO/CEM/2020/29.
This letter provides information about the change to the supply route of Pneumococcal Polysaccharide Vaccine (PPV23) for use in the NHS vaccination programme from 1 June 2021.